Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
The American Journal of Medicine|September 1, 1982
Successful treatment of skeletal hemangioma and Kasabach-Merritt syndrome with aminocaproic acid. Is fibrinolysis "defensive"?J A Neidhart, R W RoachCancer|June 15, 1984
Characterization of multiple immune defects in human malignant lymphomaR L Whisler, J L Murray, R W Roach, et al.Seminars in Oncology|September 1, 1984
A comparative trial of mitoxantrone and doxorubicin in patients with minimally pretreated breast cancerJ A Neidhart, D Gochnour, R W Roach, et al.Investigational New Drugs|September 1, 1988
A phase II evaluation of cisplatin in unresectable diffuse malignant mesothelioma: a Southwest Oncology Group StudyB L Zidar, S Green, H I Pierce, et al.Anti-Cancer Drugs|December 29, 2000
Phase II evaluation of interleukin-4 in patients with non-Hodgkin's lymphoma: a Southwest Oncology Group trialC W Taylor, M LeBlanc, R I Fisher, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Interferon versus interferon plus prednisone remission maintenance therapy for multiple myeloma: a Southwest Oncology Group StudyS E Salmon, J J Crowley, S P Balcerzak, et al.Anti-Cancer Drugs|July 8, 2000
Phase II trial of 5-fluorouracil, folinic acid and recombinant alpha-2a-interferon in patients with advanced colorectal cancerF Ravandi, M E Rytting, C Osmon, et al.Anti-Cancer Drugs|July 1, 1996
A phase II trial of piroxantrone in endometrial cancer: Southwest Oncology Group study 8918V K Malviya, P Y Liu, D A Goldberg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1993
Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: a phase III study of the Southwest Oncology GroupD R Gandara, J Crowley, R B Livingston, et al.Pageof 1